REGULATORY MANAGEMENT SOFTWARE REDUCES SUBMISSION TIME BY 80%

The only medical device RIM with integrated regulatory intelligence and AI automation.

Regulatory Management Software

TRUSTED BY LEADING COMPANIES

a red and black logo for thermo fisher scientific
a blue and white logo for acist a bracco company
a logo for a company called steris is shown
a blue and green logo for bausch + lomb
a black and white logo for helen of troy
a blue inogen logo on a white background
the word rhythm is written in blue on a white background
a medable logo that is purple and black
a black and white logo for waters tm
a truvian logo with blue dots on a white background
a blue and white logo for zimvie on a white background

What is RegDesk?

Meeting various global rules is getting more complex, and changes are happening faster. To keep up, it’s crucial to invest in an all-in-one regulatory management software. RegDesk can help.

BENEFITS OF REGDESK'S RIM PLATFORM

Prepare international applications within 1 week instead of 4 months

Reduce response time to address international inquiries from 6-8 weeks to less than 20 hours

Avoid stress and nonconformities from a Health Agency audit

Why RegDesk RIMS

With RegDesk, Regulatory Management software, enter over 120 global markets before your competitors. We make following global and local laws easy for specialized pharma and medical device companies.

This is what makes us unique

Сountries we serve

We can help you expand to 120+ markets in the world.

REGDESK REGULATORY ROUNDUP

Never miss a thing in the world of medical device regulatory compliance. The latest regulatory news and updates are always on our feed.

A Guide to Navigating Regulatory Compliance for Medical Devices

by | Jun 14, 2024 | Medical Device Regulation Resources | 0 Comments

Worldwide, medical devices are subject to strict regulations, and for good reason — they are crucial for helping health care professionals identify, treat and combat...

Medical Device Regulations in the United States

by | Jun 14, 2024 | United States,USA | 0 Comments

Medical devices are highly regulated in the United States. Since U.S. regulatory compliance for MedTech is stringent and continuously changing, staying up-to-date on...

Leveraging RIMS for Global Market Access
Leveraging RIMS Platforms for Global Market Access

by | May 29, 2024 | HSA | 0 Comments

Global market access is crucial for medical device companies looking to reach new customers, enhance brand recognition worldwide and ultimately increase revenue...

TGA on excluded software (middleware)
TGA Guidance on Excluded Software: Middleware

by | Sep 3, 2024 | Australia,TGA | 0 Comments

The new article describes in detail the regulatory approach to be applied with respect to middleware used for healthcare purposes.
TGA on excluded software (digitalisation tools)
TGA Guidance on Excluded Software: Digitalisation Tools

by | Sep 3, 2024 | Australia,TGA | 0 Comments

The new article provides additional clarifications regarding the regulatory approach to be followed with respect to the tools intended to be used for the digitalization of paper-based records used in the healthcare sphere.
TGA on excluded software (electronic heathlcare records)
TGA Guidance on Excluded Software: Electronic Healthcare Records

by | Sep 3, 2024 | Australia,TGA | 0 Comments

The new article describes additional aspects related to the regulatory status of the products for electronic healthcare records.
FDA on use-related analyses (overview)
FDA Draft Guidance on Use-Related Risk Analyses: Overview

by | Sep 3, 2024 | FDA,PDUFA,United States,URRA | 0 Comments

The article highlights the key points associated with the use-related risk analyses to be conducted with respect to various healthcare products intended to be marketed and used in the US.
FDA on use-related analyses (URRA development)
FDA Draft Guidance on Use-Related Risk Analyses: URRA Development

by | Sep 3, 2024 | FDA,PDUFA,United States,URRA | 0 Comments

The new article provides additional clarifications with respect to the development of use-related risk analyses.
FDA on use-related analyses (URRA submission)
FDA Draft Guidance on Use-Related Risk Analyses: URRA Submission

by | Sep 3, 2024 | FDA,PDUFA,United States,URRA | 0 Comments

The new article elaborates further on the submission of use-related risk analyses, and also provides certain examples intended to demonstrate the way the regulatory approach described in the guidance should be applied.
MDCG on standardisation (overview)
MDCG Guidance on Standardisation for Medical Devices: Overview

by | Sep 3, 2024 | EU,Europe,MDCG,SFHS | 0 Comments

The document outlines the approach to be followed in order to ensure standardisation for medical devices, facilitating further harmonisation of the relevant regulatory requirements.
MDCG on standardisation (harmonised standards)
MDCG Guidance on Standardisation for Medical Devices: Harmonised Standards

by | Sep 3, 2024 | EU,Europe,MDCG,SFHS | 0 Comments

The new article describes in detail the relevant harmonised standards applicable to medical devices, and also the way they should be applied.
TGA on essential principle 13B (overview)
TGA Guidance on Essential Principle 13B: Overview

by | Sep 3, 2024 | Australia,TGA | 0 Comments

The article highlights the key points related to the application of certain essential principles intended to ensure the safety and proper performance of healthcare products allowed to be marketed and used in Australia.